Class 1 recall issued for quetiapine oral suspension
Abstract
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 1 recall notice for all batches of quetiapine oral suspension (Seroquel; Eaststone Limited), after the manufacturer warned that they contain twice as much quetiapine fumarate than they should. In a national patient safety alert, issued on 29 January 2026, the MHRA said that […]
Fields of Study & Subjects
Pharmaceutical Quality and Counterfeiting
Pharmacovigilance and Adverse Drug Reactions
Healthcare Regulation
Publication details
- Journal / source
- Pharmaceutical journal/The pharmaceutical journal
- Publication date
- 1 January 2026